At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on March 1st, 2022 | 10:32 CET
Between war profits and peace dividends: ThyssenKrupp, Memiontec, BP
Since last weekend, the world has been a different place: Germany is pumping EUR 100 billion into a special fund for the German armed forces. In addition, more than the 2% of economic output demanded by the USA for years is to flow into the defense budget in the future. After years of neglecting its own defense, Germany is now back to deterrence. Given the threatening election of Donald Trump as the next US president, such self-help is also urgently needed. We highlight three stocks that are either affected by the Ukraine war or offer a peaceful alternative.
Read
Commented by Nico Popp on February 28th, 2022 | 10:33 CET
Shake-up in the auto industry - who loses, who benefits: Porsche, Altech Advanced Materials, Volkswagen
Porsche's planned IPO created a mood of celebration on the market at a turbulent time. The mood among the Porsche and Piëch families is also likely to be one of expectation. After all, they are to receive a blocking minority and would thus once again have more power over their Company. VW is also hoping for advantages from the IPO of its profitable subsidiary: For example, in investments in electromobility and in the valuation of the entire Group. Here's what the deal means for the companies involved and what the consequences could be for smaller technology providers.
Read
Commented by Nico Popp on February 25th, 2022 | 10:15 CET
Varta, Almonty Industries, NEL: New battery metal and hydrogen hope
Hydrogen is dead; are batteries the future? Not at all! If you talk to industry representatives, it quickly becomes apparent that energy sources for mobility are undergoing rapid change. Batteries that were the ultimate yesterday may be hazardous waste tomorrow. The reason: new material mixtures make batteries in electric cars more durable and better. Investors who back the wrong horse are quickly left out in the cold. Current developments in hydrogen show that even the lamest horse has a chance in the long term. We take a closer look at three shares for you.
Read
Commented by Nico Popp on February 24th, 2022 | 13:13 CET
Delivery Hero, wallstreet:online, SAP: Personnel uprising at digital companies
Nowadays, many of our wishes can be fulfilled with just a few clicks: A delicious food bowl for lunch, the latest action blockbuster or even a promising stock - after just a few clicks, we have obtained our goal. But digital business models are not always self-propelling. We get to the bottom of problems and show where opportunities still lie today. We look at the shares of Delivery Hero, wallstreet:online and SAP.
Read
Commented by Nico Popp on February 23rd, 2022 | 10:40 CET
Defence Therapeutics Interview: 'Accum™ is the most sought-after multi-tool in the pharmaceutical industry.'
The case of the German biotech CureVac has shown that costly projects often fail because of the finer details. Canadian biotech Defence Therapeutics has developed a drug enhancer with its patented Accum™ technology, which works with many technologies and, even on its own, has a highly toxic effect on cancer cells. Dr. Moutih Rafei, director and VP of research and development at Defence Therapeutics, explains in an interview how Defence Therapeutics is working toward upcoming Phase I trials around vaccines for breast and skin cancer, how else the versatile technology can be used, and to which pharma giants it has specific scientific tie-ins.
Read
Commented by Nico Popp on February 23rd, 2022 | 06:44 CET
TUI, Hong Lai Huat, Shell: 3 shares in Putin mode
Just a week ago, the mood around the TUI share was upbeat. The stock was on the road to recovery. Now the escalation around Ukraine has put a damper on it. Is the comeback now in danger? At this point, we will examine whether TUI can withstand the crisis and which values could possibly benefit from the crisis.
Read
Commented by Nico Popp on February 21st, 2022 | 15:50 CET
Daimler, Yorkton Ventures, Volkswagen: Is the lithium takeover merry-go-round about to start?
When Tesla knocks on the door, you don't keep your guest waiting long, even if the visit is spontaneous. Usually, the e-car maker brings solid plans and the necessary means to implement them. That is what happened recently with Liontown Resources. The small Australian Company plans to start commercial production by 2025. Tesla wants to get its foot in the door today and has worked out an agreement that allows for a flexible order volume, depending on how much lithium-spodumene concentrate Liontown can deliver. The deal shows even small lithium companies are in the sights of the big players. We present three stocks that could also fit the picture.
Read
Commented by Nico Popp on February 18th, 2022 | 10:33 CET
Shell, Ximen Mining, Newmont: Will gold follow the oil price rally?
Now that the oil price has long since cracked the USD 90 mark, gold is also picking up significantly. The precious metal lingered only briefly on the much-cited interest rate worries. The theoretical reasoning behind this is that if the interest rate rises, non-interest-bearing gold loses its attractiveness. This assumption has always been a bit far-fetched given the negative real yields that are expected to continue, but the gold price is now proving it: The interest rate turnaround is not relevant for gold. Instead, the general uncertainty on the market and the property as a reserve currency count. But how far can the gold rally go?
Read
Commented by Nico Popp on February 17th, 2022 | 13:21 CET
BYD, Edison Lithium, Rock Tech Lithium: Investing in the Saudi Arabia of electromobility
Ever since this year's Super Bowl, it has been clear that the future of mobility will be electric. What does one have to do with the other? Advertising space during mega-sports events is in high demand. This year, seven companies from the sector advertised e-cars and accessories, including BMW with a spot featuring Arnold Schwarzenegger. Other companies that spent up to USD 6.5 million for 30 seconds of advertising included Polestar and Nissan. But e-cars are not yet a foregone conclusion. The technology poses challenges for suppliers and raw material producers. We present three companies that are well placed to score points with their products despite adverse conditions.
Read
Commented by Nico Popp on February 16th, 2022 | 13:29 CET
Gazprom, Alerio Gold, ThyssenKrupp: Ukraine conflict resolution as a door opener?
At the moment, the world is holding its breath. Not since the end of the Cold War have so many soldiers come together on European soil as is currently the case on the border between Russia and Ukraine. While German Chancellor Olaf Scholz is focusing on diplomacy, Kiev and the Baltic states would like to see more signals of deterrence. We will see which path is the better one or whether, in the end, a combination will once again avert the worst-case scenario. However, the fact is that the threat of war is rattling the markets. We profile three stocks.
Read